Uniting Real-World
Ophthalmic Insights and
Proven Investment Experience

InFocus Capital Partners specializes in the identification, capitalization and development of breakthrough and disruptive opportunities in life sciences with an ophthalmic focus. The Fund’s experience, partnership structure and coverage of ophthalmic innovations yield a differentiated investment opportunity – optimizing the probability for successful returns.

Founders & Managing Principals

Robert Rothman

Robert Rothman, MD

Founding Partner and Principal

  • Approximately 15 years experience in venture capital deal sourcing, structuring and investing
  • Board-certified ophthalmologist and Clinical Assistant Professor of Ophthalmology at Hofstra Northwell School of Medicine
  • Partner at OCLI/Glaucoma Consultants of Long Island
  • Managing Member of the Garden City SurgiCenter
  • Past Director of Strategic Initiatives, Ophthalmology for the Northwell Health System
  • Board of Directors for Alievio, Cellview Imaging, Galidmedix and QURA, Inc.
Ron Weiss

Ron Weiss, MD

Founding Partner and Principal

  • Approximately 20 years experience in venture capital deal sourcing, structuring and investing
  • Board-certified ophthalmologist and Founder of Chicago Eye Consultants
  • Chairman of Ophthalmology at MacNeal Hospital
  • Assistant Professor of Ophthalmology at Rush University Medical Center
  • Co-founded Prescient Capital Partners in the 2001
  • Board of Directors for Cellview Imaging, Infuse Spirits, ONL, Pinstripes, 2C Tech, and Chicago Children’s Choir

Advisory Board

Stuart Abelson

CEO & Managing Partner, Ora ADG, a division of Ora, Inc.

Robert L. Avery, MD

Founder, California Retina Consultants & California Retina Research Foundation

Matthew Chapin

Senior Vice President, Corporate Development, Ora, Inc.

Philip Ferrone, MD

Managing Partner and Director of Clinical Research at Long Island Vitreoretinal Consultants

Donald Fishbein

President, Evolve Therapeutics

David L. Katz, MD

Medical Advisor, PL Developments

Jeffrey M. Liebmann, MD

Vice-Chair, and Director of the Glaucoma Division of the Department of Ophthalmology at Columbia University Medical Center

Jodi Luchs, MD, FACS

InFocus Capital Partners Chief Science Advisor & Co-Medical Director, Eyevance Pharmaceuticals

Parag A. Majmudar, MD

President & Chief Medical Officer of Chicago Cornea Consultants, Ltd.

Steven I. Rosenfeld, MD, FACS

President, Delray Eye Associates, Executive Advisor, Blue Sea Capital & Chair of Ophthalmology, Modernizing Medicine

Jeffrey Smith

Chief Executive Officer & Chief Investment Officer of Starboard Value LP

Ira J. Udell, MD

Professor and Chairman of Ophthalmology at the Zucker Hofstra Northwell School of Medicine

Charles C. Wykoff, MD, PhD

Director of Research at Retina Consultants of Houston and elected Deputy Chair of Ophthalmology for the Blanton Eye Institute

Staff

George Marinopoulos

Chief Financial Officer

Andrea Kanter

Chief Operating Officer